Skip to main content
Caplight Logo









Annoroad Gene Technology

Annoroad Gene Technology

Private
BeijingHealthcare & Life Scienceshttps://www.annoroad.com/

Last Round

Private Equity

Oct 8, 2022

Est. Valuation

$562.8M

Total Funding Raised

$156.83M

Company Overview

Annoroad Gene Technology is a biotechnology company that provides molecular-diagnostics-based IVD medical devices and multi-omics life sciences research services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

next-generation sequencingNGSclinical molecular diagnosticsgenomic research servicesbioinformatics analysisgenetic testingprecision medicineIVDin vitro diagnosticsmulti-omicsgenomic sequencingbiotech servicesclinical diagnosticsmedical instrumentsgenomics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Annoroad Gene Technology Comparables

Compare Annoroad Gene Technology with similar companies based on industry and business-model similarity.

Annoroad Gene Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Biomarker Technologies Co., Ltd.
86%
Genecast
85%
HaploX
83%

Annoroad Gene Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityOct 8, 2022
Series CNov 2, 2017
Series BAug 4, 2015
Series A ExtensionFeb 1, 2014
Series ADec 1, 2013
Angel
Jun 22, 2012

Key People

Founding team and executive leadership

李志民

CEO

Executive Team

Annoroad Gene Technology Investors

Notable investors and investment history

Annoroad Gene Technology investors
InvestorRounds
Biossom Investment ManagementSeries A Extension
Zhengxuan InvestmentAngel
Northern Light Venture CapitalSeries A Extension, Series A
德同资本Series B
Ping An VenturesSeries C
China Renaissance Capital InvestmentSeries A
Shenzhen GTJA Investment GroupSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2025

    Grew 75% QoQ, from 16 to 28 employees.

Annoroad Gene Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Annoroad Gene Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Annoroad Gene Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range28
Year Founded2012
Last FundingOct 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?